Charge-transfer complexes of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone with amino molecules in polar solvents by Berto, Silvia et al.
1 
 
 
 
This Accepted Author Manuscript (AAM) is copyrighted and published by Elsevier. It is posted here by 
agreement between Elsevier and the University of Turin. Changes resulting from the publishing process 
- such as editing, corrections, structural formatting, and other quality control mechanisms - may not be 
reflected in this version of the text. The definitive version of the text was subsequently published in 
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 149, 25 April 2015, 
10.1016/j.saa.2015.04.044.  
 
You may download, copy and otherwise use the AAM for non-commercial purposes provided that your 
license is limited by the following restrictions: 
 
(1) You may use this AAM for non-commercial purposes only under the terms of the CC-BY-NC-ND 
license.  
(2) The integrity of the work and identification of the author, copyright owner, and publisher must be 
preserved in any copy.  
(3) You must attribute this AAM in the following format: Creative Commons BY-NC-ND license 
(http://creativecommons.org/licenses/by-nc-nd/4.0/deed.en), 
http://dx.doi.org/10.1016/j.saa.2015.04.044 
 
2 
 
Charge-transfer complexes of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone with 
amino molecules in polar solvents 
 
Silvia Berto
1
, Enrico Chiavazza
1*
, Valentina Ribotta
1
, Pier Giuseppe Daniele
1
, Claudia Barolo
1,2
, 
Agnese Giacomino
3
, Davide Vione
1
, Mery Malandrino
1
 
1
 Dept. of Chemistry, University of Torino, via P. Giuria 7, 10125 Turin, Italy 
2
 INSTM and NIS Centre, University of Torino, Via Quarello 15A, 10135 Turin, Italy 
3 
Dept. of Drug Science and Technology, University of Torino, Via Giuria 9, 10125 Turin, Italy   
 
(*) Corresponding author: enrico.chiavazza@unito.it 
Telephone: 0039 011 6705259 
Postal address: via P. Giuria, 5, 10125 Torino, Italy 
 
Abstract 
The charge-transfer complexes have scientific relevance because this type of molecular interaction 
is at the basis of the activity of pharmacological compounds and because the absorption bands of 
the complexes can be used for the quantification of electron donor molecules. This work aims to 
assess the stability of the charge–transfer complexes between the electron acceptor 2,3-dichloro-
5,6-dicyano-1,4-benzoquinone (DDQ) and two drugs, procaine and atenolol, in acetonitrile and 
ethanol. The stability of DDQ in solution and the time required to obtain the maximum complex 
formation were evaluated. The stoichiometry and the stability of the complexes were determined, 
respectively, by Job’s plot method and by the elaboration of UV-vis titrations data. The latter task 
was carried out by using the non-linear global analysis approach to determine the equilibrium 
constants. This approach to data elaboration allowed us to overcome the disadvantages of the 
classical linear-regression method, to obtain reliable values of the association constants and to 
calculate the entire spectra of the complexes. NMR spectra were recorded to identify the portion of 
the donor molecule that was involved in the interaction. The data support the participation of the 
aliphatic amino groups in complex formation and exclude the involvement of the aromatic amine 
present in the procaine molecule.  
Keywords: CT complexes, DDQ, Procaine, Atenolol, Spectrophotometry, NMR 
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1. Introduction 
 
The charge-transfer (CT) complexes formed from the reaction of electron acceptors with donors 
containing heteroatoms, such as nitrogen, sulphur or oxygen, have seen a growing importance in 
recent years. Some studies on acceptor-donor systems were performed to characterize the nature, 
the kinetic and the stability of the complexes in different organic solvents (Arslan, 2007; Datta, 
2008; Duymus, 2006; Eldaroti, 2014; Ganesh, 2011; Karmakar, 1991; Pandeeswaran, 2006, 2008, 
2009, 2010; Refat, 2006; Sharma, 2012). Other works report the application of this type of 
interaction for the quantitative determination of the donor molecules, including the quantification of 
pharmaceutical products (Abdel-Hamid, 1985; Ahmed Siddiqui, 2010; El-Mammli, 2003; Fathima, 
2011; Refat, 2006; Salem, 2002; Veeraiah, 2005). The peculiarity of the CT complexes is their 
elevated absorption in the visible range, where donor and acceptor usually do not absorb. Therefore, 
the absorbance values at the wavelengths of maximum absorption are used for the quantification of 
the drugs in pharmaceutical formulates. Typical electron acceptors are the 2,3-dichloro-5,6-
dicyano-1,4-benzoquinone (DDQ), 2,3-dibromo-5,6-dicyano-1,4-benzoquinone (DBQ), 
tetracyanoquinodimethane (TCNQ), tetracyanoethylene (TCNE), 2,3,5,6-tetrabromo-1,4-
benzoquinone (bromanil), 2,3,5,6-tetrachloro-1,4-benzoquinone (chloranil), dinitrobenzene (DNB) 
(Rosokha, 2008). The donors are usually molecules with nitrogen or sulphur atoms, having free 
electron pairs or electron-rich aromatic rings.  
In most literature reports, the evaluation of the stability of the complexes has been performed with 
linear regression methods, such as the Benesi-Hildebrand or Scott equation. However, it has long 
been known (Foster, 1969; Thordarson, 2011) that these methods: i) may be affected by lack of 
linearity; ii) can give negative intercepts that hinder the calculations; iii) are limited by the 
assumption of the formation of a single complex in 1:1 stoichiometric ratio; iv) have to respect the 
conditions CA >> CD (CA = concentration of the acceptor, CD = concentration of the donor), or 
CA<< CD, on which the development of the entire equation is based. 
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In this work, we studied the interaction of the acceptor DDQ with molecules containing nitrogen 
atoms in acetonitrile and ethanol. The stoichiometry and the stability of the complexes were 
determined, respectively, by Job’s plot method and by the elaboration of UV-vis titrations data. The 
data collection was achieved by applying the same approach used in the evaluation of the 
association constants in supramolecular chemistry (Thordarson, 2011). This approach is directly 
derived from the chemical equilibrium theory, and the data elaboration was performed by a 
software, HypSpec®, dedicated to the determination of equilibrium constants from 
spectrophotometric data. The software can process the entire UV-vis spectrum and it calculates the 
stability constants with an iterative method. The single requirement is that the spectral intensity of 
each chemical species should be proportional to the concentration of that species in solution.  
Because preliminary experiments suggested that DDQ preferentially interacts with non-aromatic 
amines, we chose to study the interaction of DDQ with two pharmaceuticals that contain aliphatic 
amino groups: a -adrenergic blocker (atenolol) and a synthetic local anaesthetic drug (procaine; 
see Figure 1 for their molecular structures). Both molecules have nitrogen functions that could 
interact with DDQ: procaine has an aliphatic and an aromatic amine, while atenolol has an amino 
and an amidic nitrogen. NMR spectra were recorded to identify the portion of the donor molecule 
that is involved in the interaction. Optimal working conditions were assessed, evaluating the 
stability of DDQ in solution and the time required to obtain the maximum complex formation.  
 
 
 
a 
 
 
b 
 
 
 
c 
Figure 1. Donor molecules studied: a) Atenolol, b) Procaine, c) 2,3-dichloro-5,6-diciano-1,4-
benzoquinone (DDQ). 
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2. Experimental 
 
2.1 Chemicals 
2,3-Dichloro-5,6-dicyano-1,4-benzoquinone (DDQ) (purity 98%), atenolol (purity ≥98%); procaine 
hydrochloride (purity 99.9%), tetrabutylammonium hydroxide solution (0.1 mol L
-1
 in organic 
solvent, which is a mixture of 2-propanol and methanol), ethanol (≥99.8%) and acetonitrile (99.9%) 
were Sigma Aldrich products. Ethanol-d6 (anhydrous, ≥99%) and acetonitrile-d3 (≥99.8%) were 
Euriso-top products. 
The solutions of the donors were prepared by dissolving the drugs in the solvent and were stored at 
4°C. The solutions of the acceptor molecule (DDQ) were always freshly prepared.  
Procaine does not interact with DDQ if it is protonated, which is the case for the commercial 
(hydrochloride) form. Therefore, we used the commercial solution of tetrabutylammonium 
hydroxide to neutralize the procaine solutions, immediately before mixing them with DDQ. 
 
2.2 Spectroscopic measurements 
The UV-visible molecular absorption spectra (300-600 nm) of the donor-acceptor systems were 
recorded with a V-550 Jasco spectrophotometer, equipped with 1.000 cm or 5.00 cm quartz cells 
(Hellma), and working with a 200 nm/min scanning speed and 1.0 nm band width.  
1
H-NMR measurements at variable temperature were performed on a Jeol EX 400 spectrometer (B0 
= 9.4 T, work frequency 
1
H = 399.78 MHz), in common 5mm NMR tubes, while titrations were 
performed on a Bruker Avance 200 (B0 = 4.7 T, work frequency 
1
H = 399.78 MHz) spectrometer. 
In titration experiments, the drugs concentration was kept constant at 10 mmol L
-1
 while the DDQ 
concentration was varied from zero to 15 mmol L
-1
. 
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2.3 Optimisation of working conditions 
In order to obtain stable and coherent results, we evaluated preliminarily the stability of the DDQ 
absorption spectra in the two polar solvents and the time necessary to reach the maximum complex 
formation. As far as the first issue is concerned, DDQ spectra change over time and show an 
increase of the absorbance values in the same range of the CT-complexes (400-550 nm). The 
spectral features are in agreement with those reported for the DDQ
•
 radical ion (Miller, 1986). 
In order to assess the sensitivity of DDQ to atmospheric exposure, we recorded the time trend of the 
absorbance of 5∙103 mol L1 DDQ in ethanol and acetonitrile under environmental atmospheric 
conditions, or by bubbling nitrogen into the solvent before use and in the solution after preparation. 
The absorbance was recorded at 460 nm, where absorption by the CT-complexes under study is 
maximum. To assess the complex development, the spectra of equimolar solutions of DDQ/drug 
were recorded during time and the absorbance at 460 nm was monitored. Both solvents were used 
for subsequent studies. 
 
2.4 Job’s plot method 
The Job’s plot method was used to evaluate the stoichiometry of the CT-complexes in the two 
solvents. The drug and the DDQ stock solutions (all 5·10
3 
mol L
1
) were prepared in acetonitrile or 
ethanol. Then, for each solvent, 9 donor-acceptor solutions were prepared in 10 mL volumetric 
flasks. In each case, the content of acceptor and donor was chosen so as to vary their molar fractions 
but not the total concentration (sum of acceptor and donor concentrations). The spectrum of each 
solution was recorded between 300 and 600 nm, with an optical path of 1.000 cm. The absorbance 
at 460 nm was reported in the Job’s plot as a function of the solution molar fraction,  = Cdrug/(Cdrug 
+ CDDQ). 
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2.5 Spectrophotometric titration 
Spectrophotometric titrations were conducted with the batch method to better control the 
atmospheric conditions and the time elapsed from the mixing of the components. The single 
solutions were prepared by adding an aliquot of the drug solution, different fixed volumes of the 
DDQ solution (increasing in different experiments, so as to carry out the titration in several single 
steps) and a volume of solvent, so as to reach always the same total volume (10 or 20 mL). Each 
solution thus prepared was maintained at 25 ± 0.1°C and an aliquot was taken to record the UV-vis 
spectrum. The working concentration of the drugs ranged between 2·10
5
 and 5·10
4
 mol L
1
. The 
optical paths were 1.000 cm for the less diluted solutions, and 5.00 cm for the lowest 
concentrations. The molar ratios DDQ/drug ranged between 0 and 10.  
 
2.6 Data elaboration 
The titration data were elaborated with the HypSpec® software (Gans, 1996), to calculate the 
formation constants and the molar absorptivity of the CT-complexes for each system. 
 
3. Results and Discussion 
 
3.1 Kinetics and stoichiometry of the CT-complexes 
A detailed kinetic study was beyond the scope of this work, but a qualitative evaluation of the 
kinetics of formation of the complexes was attempted, since it evolves during time (Pandeeswaran, 
2008). Moreover, to assess reliable association constants, it is necessary to identify an elapsed time 
from the mixing of the solutions, after which the complexes are completely formed and the 
measured spectra are reproducible. 
A problem with DDQ is the formation of the absorbing species DDQ
•
. Figure 2 shows the 
absorbance trend as a function of the elapsed time, for DDQ solutions in ethanol. It is possible to 
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observe that, when nitrogen was bubbled in the solvent, the absorbance increase was less important. 
A very similar behaviour was obtained in acetonitrile.  
Figure 3 shows the absorbance trend of DDQ/drug solutions as a function of the elapsed time. 
Stable absorbance values were reached about 15 minutes after solution preparation. It is also 
evident that the signals were lower in ethanol compared to acetonitrile, but the results in ethanol 
were more stable. Therefore, to allow complex formation but to minimize, at the same time, the 
interference of DDQ
•
 on the absorption spectra, the  experiments that follow were conducted with 
solutions prepared in inert atmosphere. The signals of the complexes were recorded after exactly 15 
minutes from the solutions preparation. 
Figure 4 shows the Job’s plots obtained for the four studied systems (DDQ-procaine and DDQ-
atenolol in both solvents). All the plots have maxima at a molar fraction of 0.5, thus the 
stoichiometry of the CT-complexes looks to be 1:1. 
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Figure 2. Absorbance at 460 nm of a 5∙103 mol L1 DDQ solution in ethanol (optical path: 1.000 
cm). Black points: solution prepared in atmospheric conditions. Red points: solution prepared in 
inert atmosphere, obtained by bubbling nitrogen in the solvent before and after the solution 
preparation. 
9 
 
0 400 800 1200 1600 2000
0.0
0.2
0.4
0.6
0.8
1.0
A
b
s
4
6
0
 n
m
time (s)
 Atenolol-DDQ in acetonitrile
 Atenolol-DDQ in ethanol
 Procaine-DDQ in acetonitrile
 Procaine-DDQ in ethanol
 
Figure 3. Time course of CT-complex formation in ethanol and acetonitrile. The absorbance at 460 
nm of 4∙105 mol L1 drug solutions was measured with one equivalent of DDQ added (optical path: 
5.00 cm). 
 
 
Figure 4. Job’s plots of the CT-complexes, in acetonitrile (A) and ethanol (B), for DDQ-Atenolol 
(red) and DDQ-Procaine (black) systems. 
 
3.2 Stability of the complexes 
Spectrophotometric batch titrations were conducted to evaluate the stability of the CT-complexes. 
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0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.2
0.4
0.6
0.8
1.0
1.2
A
A
b
s
4
6
0
 n
m
Molar fraction
0.0 0.2 0.4 0.6 0.8 1.0
0.0
0.2
0.4
0.6
0.8
1.0
B
A
b
s
4
6
0
 n
m
Molar fraction
10 
 
concentration of the components: DDQ, drug and CT-complex. In the cases under study, for not 
excessive concentration of free DDQ, the complex is the only species that absorbs in the range 400 - 
600 nm. Therefore, in this wavelength interval, the absorbance is directly proportional to the 
complex concentration or to its molar fraction. An example of spectra obtained for the system 
DDQ-procaine in ethanol is reported in Figure 5. By merely looking at the data obtained from the 
spectrophotometric titration, it is possible to estimate the values of the association constants. As 
reported by Thordarson (2011), the binding isotherm (the diagram of the molar fraction of the 
complex, measured by its absorbance change, vs. the equivalents of titrant added, [DDQ]0/[drug]0) 
changes its features as a function of the ratio [drug]0/Kd. Here Kd is the dissociation constant of the 
complex, calculated as the reciprocal of the association constant, 1/Ka. If [drug]0/Kd > 100, the trend 
is linear till 1 equivalent of titrant added ([DDQ]0/[drug]0 = 1), after which point the absorbance 
does not change any longer. In contrast, if [drug]0/Kd < 100, the absorbance increases continuously 
also after 1 equivalent of titrant added. The latter case is preferred, because more titration points can 
be used for Ka evaluation and the uncertainty on Ka gets lower.  
Figure 6 shows the trends of the absorbance (at the wavelength of maximum absorbance, 460 nm) 
vs. the equivalents of titrant added, [DDQ]0/[drug]0, for systems where [drug]0 was about 410
5
 mol 
L
1
 (experimental data obtained at different concentration levels are reported in Figure S1 of the 
Supplementary Material file). The trends reported in Figure 6a correspond to data obtained by 
waiting for 15 minutes after the mixing of the components, and the last data points have a little 
excess of DDQ added. In contrast, Figure 6b reports points with higher concentrations of DDQ. In 
this case the measurements were executed immediately after the solution preparation, in order to 
avoid DDQ degradation. The systems DDQ-atenolol, in both solvents, show a very low increase of 
the absorbance of the drug solution for [DDQ]0/[drug]0 > 1. This trend is characteristic for systems 
that have [drug]0/Kd  10 (Thordarson, 2011), from which we can suppose that logKa  5.4. A 
different behaviour can be observed for procaine in ethanol, from which it is possible to suppose a 
lower formation constant of the CT-complex. Moreover, after 1 equivalent of DDQ added, waiting 
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for 15 minutes after the solution preparation (Figure 6a), there is a singularity in the trend which 
suggests that a different reaction between the components is taking place, such as a degradation or 
an association process. For this reason, the spectra thus obtained were not used for the Ka 
calculation when [DDQ]0/[procaine]0 > 1. The system with procaine in acetonitrile showed a 
singular behaviour: replicates of the same solution showed different spectra in the same conditions 
of temperature, mixing order, elapsed time and freshness of the stock solutions. The reactivity of the 
system was not clear and, as a consequence, it was not possible to calculate the association constant 
and the spectral parameters of the complex in acetonitrile. 
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Figure 5. UV-vis spectra recorded on solutions containing different molar ratios of DDQ and 
atenolol in ethanol, with [drug]0 = 3.9·10
-5
 mol L
-1
 and optical path 5.0 cm. 
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Figure 6. Absorbance at 460 nm as a function of the equivalents of acceptor added,  
[DDQ]0/[drug]0, for the following systems: atenolol 3.96·10
-5
 M in acetonitrile (black), atenolol 
3.95·10
-5
 M in ethanol (red), procaine 3.93·10
-5
 M in ethanol (blue).  a) The absorbance values were 
recorded after 15 minutes from the mixing of the components; b) the absorbance values were 
recorded immediately after the mixing of the components and were corrected subtracting the 
absorbance due to the excess of DDQ in solution. 
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In order to measure the values of the CT-complexes association constants, the experimental spectra 
were elaborated with HypSpec®. For the system atenolol-DDQ in ethanol, the absorbance did not 
change very much with the waiting time. Therefore, also the spectra recorded with high excess of 
DDQ were elaborated. In the case of atenolol-DDQ in acetonitrile, only the spectra obtained by 
waiting for 15 minutes and with no more than 1.2 equivalents of DDQ were elaborated. The reason 
is that there was a non-negligible increase in the concentration of the complex during the waiting 
time. In this system, the need to wait for the complete formation of the complexes and the 
instability of the components provided spectra that were not consistent with one another, in the 
presence of an excess of DDQ.  
Table 1 reports the association constants obtained for the three systems. The values are in 
agreement with the qualitative analysis of the diagrams Abs460nm vs. [DDQ]0/[drug]0, already 
discussed. The formation percentages of the CT-complexes, calculated by the application of the 
association constants obtained for the system atenolol-DDQ, reach values of about 88% when 1.1 
equivalents of titrant are added to 4105 mol L1 drug solutions, in agreement with the trends of the 
absorbance reported in Figure 6. For concentrations of drug higher than 2104 mol L1, at the same 
titration point, the formation percentages of the CT-complexes reach values of about 98% and, 
consistently, one observes the stabilization of the experimental absorbance values (see 
Supplementary Material). In the case of procaine, about 65% of the drug would be involved in 
complex formation when 1 equivalent of DDQ is added to a 4105 mol L1 drug solution. 
The values of max are similar for all the complexes, but the complex in acetonitrile has a 
significantly higher value of max. The spectra of the single complexes, also obtained with 
HypSpec®, are reported in Figure 7. 
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Figure 7. a) Spectra of the single components of the solutions 1·10
-4
 mol L
-1
. The spectra of 
atenolol are not reported because it does not absorb in the range 300-600 nm. b) Absorption spectra 
of the complexes DDQ-procaine (blue: in ethanol) and DDQ-atenolol (red: in ethanol; black: in 
acetonitrile), calculated with HypSpec®.   
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Table 1. Association constants, wavelengths of maximum absorbance and the corresponding molar 
absorption coefficients of the CT-complexes of DDQ with atenolol and procaine, in acetonitrile and 
ethanol (t = 25°C). 
a standard deviation calculated on the logK obtained by the elaboration of the single titration by HypSpec®.  
b number of total spectra elaborated.  
 
3.3 NMR spectra 
The 
1
H-NMR spectra of the drugs recorded at room temperature in deuterated acetonitrile and 
ethanol, before and after the addition of DDQ, allowed us to define the portion of the donor 
molecule involved in complex formation. Through NMR titration, it was also possible to support 
the values of the formation constants determined above. On the other hand, the spectra recorded at 
lower temperatures (183K<T<273K) had the purpose of establishing whether the complex would be 
in a fast exchange regime or a stable pair.  
Donor-acceptor (D-A) solutions were freshly prepared, directly in a NMR tube with a variable D/A 
ratio (1:0.2-1.5), they were mixed and measured after an average time of 15 minutes. The formation 
of the complexes was easily monitored in the NMR spectra by the shift of the NMR signals in the 
molecular region of interest. In both drugs the complex formation appears as a continuous shift of 
the proton signals adjacent to the nitrogen donor (Figures 8-9): 
1
H-NMR of procaine in CD3CN ∂ 
CH3 3H(t) 1.03 ppm, 1.33 ppm before and after equimolar addition of DDQ;
 1
H-NMR of atenolol in 
CD3CN ∂ CH3 3H(d) 1.02 ppm, 1.35 ppm before and after equimolar addition of DDQ. Similarly, 
1
H-NMR of procaine in CD3CD2OD ∂ CH3 3H(t) 1.01 ppm, 1.31 ppm before and after equimolar 
addition of DDQ;
 1
H-NMR of atenolol in CD3CD2OD ∂ CH3 3H(d) 1.01 ppm, 1.37 ppm before and 
after equimolar addition of DDQ (spectra not shown). The drift stopped after the addition of an 
Drug 
Acetonitrile Ethanol 
logKa ± sd
a
 n. spectrab 
max 
(nm) 
max ± sd
a
 
(mol-1 cm-1 L) 
logKa ± sd n. spectra
b 
max 
(nm) 
max ± sd 
(mol-1 cm-1 L) 
Atenolol 5.9 ± 0. 2 24 458 3306 ± 71 5.9 ± 0.3 23 462 1617 ± 53 
Procaine n.d.  n.d. n.d. 3.9 ± 0.2 24 462 2104 ± 86 
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equimolar quantity of DDQ (nested graphs in Figures 8-9). Note that, due to the relatively low 
sensitivity of the NMR technique, the relevant experiments were carried out at quite elevated drug 
concentration ([drug]0 = 10 mmol L
1
) compared to the spectrophotometric runs. The reported 
behavior is in good agreement with the spectrophotometric data that were obtained on solutions 
with the most elevated values of [drug]0 (2 10
4
 or 5104 mol L1, see Supplementary Material). 
For both drugs, the NMR data support the participation of the aliphatic amine to complex formation 
and exclude the involvement of the aromatic amine present in the procaine molecule (see Figure 
10). In a similar case (Demirhan, 2013), the literature reports the formation of the D-A complex as a 
dative bond between the involved molecular regions, with the successive formation of a couple of 
radicals anion and cation. 
The spectra recorded at low temperature in ethanol-d6, and even at 183 K (data not shown), did not 
display any effect of separation between the signal of the unbound drug and that of the formed 
complex. The reason of this behavior could be either a very fast ligand exchange or a temperature-
independent process. 
 
Figure 8. 
1
H-NMR spectra of the drug in acetonitrile-d3, before and after the addition of 0.5 
equivalents of DDQ: Procaine 10.0 mmol L
-1
 (red), Procaine 10.0 mmol L
-1
 and DDQ 5.0 mmol L
-1
 
(blue); nested graph: 
1
H-NMR CH3-region shift observed during titration. 
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Figure 9. 
1
H-NMR spectra of the drug in acetonitrile-d3, before and after the addition of 0.5 eq of 
DDQ: Atenolol 10.0 mmol L
-1
 (red), Atenolol 10.0 mmol L
-1
 and DDQ 5.0 mmol L
-1
 (blue); nested 
graph: 
1
H-NMR CH3-region shift observed during titration. 
 
 
Figura 10. Molecular structures of compounds and their correspondent charge transfer 
complexes. 
10mM DDQ 
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4. Conclusion 
The approach used here for the evaluation of the association constants allowed us to overcome the 
disadvantages of the classical linear-regression methods. Therefore, the present values of the 
stability constants should be more reliable than those previously evaluated, by using Benesi-
Hildebrand plots, for the complex atenolol-DDQ in acetonitrile (Salem, 2002) and for atenolol-
DDQ in 2-methyl-2-propanol (Pandeeswaran, 2008) (although in the latter case a different solvent 
was used compared to the present work). The association constants obtained in this work are 
significantly higher than those reported in previous papers, but the values obtained here are in close 
agreement with the experimental trends of the spectrophotometric titrations. In contrast, such trends 
would not be consistent with significantly lower values of the association constants. Therefore, the 
application of traditional methods seems to provide underestimated values for these systems. 
Moreover the use of a non-linear global analysis, allowing the elaboration of the entire spectra and 
not only of a few absorbance values, has some additional advantages: it is possible to elaborate a 
data matrix, and one can calculate the spectrum of the complex and control its coherence with the 
experimental spectra profiles. The latter opportunity was useful in the present case, because the 
tendency of DDQ to be transformed into the radical DDQ
•
 can affect the repeatability of the 
spectral measurements. Although we tried to minimize the DDQ
•
 formation by maintaining the 
solutions under inert atmosphere and by executing batch titrations, the occurrence of the radical was 
found to disturb the measurements, especially on solutions containing excess DDQ. This problem 
was found to be minor when using ethanol as solvent (in agreement with the results shown in Figure 
2). Only the spectra that were coherent with each other were used for the association constant 
elaboration. The anomalous spectra could be easily found with the software application. Despite 
this possibility, the uncertainty on the values of the association constants remains high, as reported 
in Table 1. 
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Figure 1S. Experimental trends of the absorbance (at the 
wavelength of maximum absorbance, 460 nm) vs. the 
equivalents of titrant added, [DDQ]0/[drug]0, for the 
different systems at several concentration levels. 
